iotaSciences, a company dedicated to accelerating cell-line engineering projects, has closed its Series B funding round, securing $5.0M. The capital infusion marks a notable moment for the firm as it continues to develop its specialized offerings.
The company provides powerful automation solutions and custom services tailored for the complex demands of biotech research. These offerings are designed to streamline critical processes, enabling scientists and engineers to enhance efficiency and precision in their work.
